APA (7th ed.) Citation

Lee, S., Powis, J., Heathcote, E., Sherman, M., Bailey, R., Feinman, S., . . . Peltekian, K. (2006). 593 Treating chronic hepatitis C with peginterferon alpha-2a (40KD) (PEGASYS®) plus ribavirin in routine clinical practice: Factors predicting SVR using multiple logistic regression analysis. Journal of Hepatology, 44, S220. https://doi.org/10.1016/s0168-8278(06)80593-3

Chicago Style (17th ed.) Citation

Lee, S.S, et al. "593 Treating Chronic Hepatitis C with Peginterferon Alpha-2a (40KD) (PEGASYS®) Plus Ribavirin in Routine Clinical Practice: Factors Predicting SVR Using Multiple Logistic Regression Analysis." Journal of Hepatology 44 (2006): S220. https://doi.org/10.1016/s0168-8278(06)80593-3.

MLA (9th ed.) Citation

Lee, S.S, et al. "593 Treating Chronic Hepatitis C with Peginterferon Alpha-2a (40KD) (PEGASYS®) Plus Ribavirin in Routine Clinical Practice: Factors Predicting SVR Using Multiple Logistic Regression Analysis." Journal of Hepatology, vol. 44, 2006, p. S220, https://doi.org/10.1016/s0168-8278(06)80593-3.